Fact-checked by Grok 2 weeks ago

Necrosis

Necrosis is the pathological death of cells and tissues in a living , typically resulting from acute and irreversible that overwhelms cellular repair mechanisms, leading to uncontrolled breakdown of cellular structures, plasma membrane rupture, and release of intracellular contents that trigger an inflammatory response. Unlike apoptosis, which is a programmed and orderly process that avoids inflammation, necrosis is passive and chaotic, often manifesting as swelling of organelles (oncosis), nuclear condensation (), fragmentation (), or dissolution (), ultimately causing tissue damage. This form of has been recognized since the , with the term derived from the Greek nekros meaning "dead body," and it serves as a hallmark in for diagnosing various diseases. The primary causes of necrosis include from ischemia or , where insufficient blood supply deprives cells of oxygen and nutrients; physical such as burns or mechanical injury; chemical and toxin exposure, including poisons or therapeutic agents; infectious agents like or viruses; and immunological reactions involving immune-mediated damage. These insults disrupt cellular , leading to loss of membrane integrity, influx of ions and water, mitochondrial dysfunction, and activation of lysosomal enzymes that digest cellular components. In recent understandings, while classical necrosis is considered accidental and unregulated, emerging highlights regulated forms such as necroptosis, a programmed necrotic pathway involving receptor-interacting protein kinases ( and RIPK3) and mixed lineage kinase domain-like protein (MLKL), triggered by stimuli like (TNF) under conditions where is inhibited. Additionally, as of 2025, studies have described PANoptosis, a coordinated inflammatory integrating , , and necroptosis, highlighting further complexity in regulated necrosis pathways. Necrosis presents in distinct morphological types based on the underlying cause, affected tissue, and progression: coagulative necrosis, the most common, preserves cellular outlines with denatured proteins and is seen in hypoxic injury to organs like the heart or kidney; liquefactive necrosis, involving tissue digestion into a liquid viscous mass, occurs in bacterial infections or the central nervous system; caseous necrosis, with a cheese-like appearance, is characteristic of granulomatous diseases such as tuberculosis; fat necrosis, resulting from enzymatic digestion of adipose tissue, as in acute pancreatitis; gangrenous necrosis, a form of coagulative necrosis with bacterial superinfection leading to putrefaction, often in extremities; and fibrinoid necrosis, involving vessel wall damage in immune or hypertensive conditions. These patterns are identified histopathologically and guide etiological diagnosis. Clinically, necrosis contributes to numerous conditions, including , , , and organ failure, where it amplifies tissue injury through secondary and impairs organ function. Understanding necrosis not only aids in pinpointing disease mechanisms but also informs therapeutic interventions, such as restoring blood flow in ischemia or targeting regulated pathways like necroptosis with inhibitors of to mitigate inflammatory damage in autoimmune or neurodegenerative disorders. Ongoing into the molecular regulators of necrosis continues to reveal its role in both and potential therapeutic modulation.

Overview

Definition and characteristics

Necrosis is defined as the premature death of cells and living tissue resulting from irreversible damage, typically caused by external injuries such as ischemia, trauma, or toxins, in contrast to programmed cell death mechanisms. This process is passive and uncontrolled, distinguishing it from regulated forms of cell death like apoptosis. The term "necrosis" originates from the Greek word nekrosis, meaning "death" or "the act of killing," derived from nekros ("dead body"), and entered English medical usage in the late 16th century (first recorded in 1583), though its application in pathology became prominent in the mid-19th century with the work of Rudolf Virchow. Key characteristics include cellular swelling known as oncosis, rupture of the plasma membrane, and eventual lysis of the cell, leading to the release of intracellular contents into the surrounding tissue. This uncontrolled breakdown involves autolysis, where the cell's own enzymes digest its components, and heterolysis, where enzymes from neighboring cells or immune cells contribute to degradation, often provoking an inflammatory response. The leakage of cellular contents exposes damage-associated molecular patterns (DAMPs), which alert the immune system and amplify inflammation. Biologically, necrosis plays a critical role in tissue dysfunction across various pathologies, such as from vascular occlusion, due to coronary artery blockage, and ischemic from cerebral blood flow interruption. By disrupting tissue integrity and eliciting sterile inflammation through DAMP release, necrosis exacerbates organ damage and contributes to disease progression in these conditions. Unlike , which is non-inflammatory and orderly, necrosis's messy nature often leads to secondary tissue injury via immune activation.

Comparison with other cell death types

Necrosis represents an uncontrolled, passive form of induced by severe exogenous or endogenous insults, characterized by rapid plasma membrane rupture, swelling, and uncontrolled release of intracellular contents that trigger via damage-associated molecular patterns (DAMPs) such as HMGB1. In stark contrast, is a highly regulated, programmed process that promotes orderly cellular dismantling through activation, resulting in non-inflammatory apoptotic bodies that are efficiently phagocytosed by neighboring cells or macrophages, thereby avoiding immune activation and tissue damage. While necrosis typically affects clusters of cells leading to widespread tissue injury, proceeds in individual cells without compromising membrane integrity during execution. Necroptosis, often considered a regulated variant of necrosis, mimics the lytic and inflammatory morphology of classical necrosis but is genetically orchestrated through the receptor-interacting 3 (RIPK3) and mixed kinase domain-like (MLKL) pathway, which forms membrane pores under conditions where is blocked, such as inhibition. This pathway enables necroptosis to serve adaptive roles in host defense against pathogens, distinguishing it from the accidental of unregulated necrosis, though both culminate in DAMP release and proinflammatory responses. Other regulated necrotic pathways further delineate necrosis. Pyroptosis, driven by activation and gasdermin D-mediated pore formation, leads to release (e.g., IL-1β) and is tightly linked to innate immunity, differing from classical necrosis by its caspase-1 dependence and rapid execution in response to microbial stimuli. Ferroptosis, conversely, arises from iron-catalyzed accumulating toxic hydroperoxides in membranes, representing a metabolism-dependent mode without the broad triggers of necrosis, though it similarly results in cell lysis and potential . Evolutionarily, necrosis embodies an , unregulated cellular response to lethal stresses that likely predates the emergence of multicellular , serving as a default failure mode without adaptive control. Programmed deaths like , however, evolved subsequently in metazoans to enable precise sculpting and , integrating with developmental signaling to suppress and support organismal complexity.

Classification

Morphological patterns

Necrosis manifests in several distinct morphological patterns, each characterized by specific gross and microscopic features that reflect the nature of destruction. These patterns are identified through histopathological and are crucial for diagnosing underlying pathological processes. The primary types include coagulative, liquefactive, caseous, fat, fibrinoid, and gangrenous necrosis, differentiated by the preservation or degradation of cellular architecture and the composition of necrotic debris. Coagulative necrosis is the most common pattern, where the basic outline of the tissue architecture is preserved despite cell death, due to protein denaturation that imparts an eosinophilic, anucleate appearance to cells under microscopy. Microscopically, affected cells retain their shape but lose nuclei and exhibit a ghostly, hypereosinophilic cytoplasm, eventually cleared by phagocytic cells. This pattern predominates in ischemic injuries to solid organs such as the heart, kidney, and spleen. Liquefactive necrosis involves rapid digestion of necrotic tissue by hydrolytic enzymes from neutrophils or the cells themselves, resulting in a viscous, liquid mass that transforms the area into a cyst-like structure. Grossly, it appears as a soft, liquefied area, while microscopically, there is complete loss of structural detail with fragmented debris and inflammatory cells. It is typical in bacterial abscesses and hypoxic infarcts, where the 's high and water content facilitates enzymatic breakdown. Caseous necrosis presents as a cheese-like, amorphous, whitish-gray with a crumbly on gross examination, lacking the preserved seen in . Microscopically, it consists of acellular, to basophilic granular material surrounded by granulomatous . This pattern is hallmark of granulomatous infections, particularly , where it forms the central core of caseating granulomas. Fat necrosis features the enzymatic digestion of adipose tissue, leading to saponification where fats react with calcium to form chalky white deposits. Grossly, it appears as firm, opaque nodules, and microscopically, ghost-like adipocytes with basophilic calcium deposits and surrounding inflammation are evident. It commonly occurs in acute pancreatitis due to lipase release or in breast tissue following trauma. Fibrinoid necrosis is characterized by the deposition of fibrin and immune complexes within vessel walls, giving a bright pink, amorphous, smudgy appearance on hematoxylin and eosin staining. It primarily affects arterioles and small arteries, with necrosis limited to the vessel wall rather than surrounding parenchyma. This pattern is seen in immune-mediated conditions such as hypertensive crises and various vasculitides. Gangrenous necrosis is a clinical term describing extensive necrosis often involving limbs or digits, subclassified into dry and wet forms based on secondary . Dry gangrene results from pure ischemia, yielding a mummified, shrunken, black appearance with preserved coagulative features; wet gangrene involves superimposed bacterial , leading to liquefactive changes, , and a foul-smelling, moist . It typically affects in peripheral .

Clinical and etiological types

Necrosis can be classified clinically based on its presentation and etiologically according to the underlying causative factors, providing insights into disease progression and management beyond mere histological appearance. These classifications highlight how necrosis manifests in specific body regions or contexts, often influenced by ischemia, infection, or toxins, and guide therapeutic approaches tailored to the clinical syndrome. Gangrene represents a severe clinical form of necrosis involving large areas, typically in , and is subdivided into subtypes based on and . Dry gangrene arises from leading to progressive ischemia without significant bacterial involvement, resulting in mummified, shriveled that appears black and dry; it is most common in . Wet gangrene develops when bacterial complicates ischemic , causing , , and a moist, foul-smelling appearance due to liquefactive processes; it spreads rapidly and requires urgent . , a life-threatening variant, is primarily caused by infection in deep wounds, producing gas bubbles and systemic toxicity through toxin release, often exhibiting on . Avascular necrosis, also known as osteonecrosis, is a clinically distinct type involving death due to interrupted supply, commonly affecting weight-bearing joints like the . In , vaso-occlusive crises lead to ischemia in the , with approximately 30% of patients developing this complication, progressing to joint collapse and if untreated. Etiologically, necrosis can stem from various origins, each presenting unique clinical features. Traumatic necrosis occurs following direct physical injury, such as crush wounds or burns, where mechanical damage disrupts vascular integrity and induces rapid in affected tissues. Radiation-induced necrosis emerges as a delayed complication of cancer radiotherapy, particularly in or head-and-neck tumors, where damages endothelial cells, causing vascular occlusion and focal death months to years post-treatment. Chemical necrosis results from exposure to toxins, exemplified by venom, which contains sphingomyelinase D that hydrolyzes cell membranes, leading to localized dermonecrotic lesions with ulceration and formation. Special cases illustrate necrosis's role in broader biological contexts. In solid tumors, central necrosis arises from due to inadequate vascularization, where rapid outpaces supply, creating avascular cores that undergo coagulative and influence tumor aggressiveness. Conversely, in blind mole rats (Spalax ehrenbergi), a hyperactive necrotic pathway mediated by interferon-beta and activation confers cancer resistance; aberrant cell crowding triggers rapid necrosis, preventing in this long-lived, hypoxia-tolerant species.

Causes

External factors

External factors encompass various environmental and physical agents that can trigger necrosis by directly damaging tissues or disrupting vascular integrity from outside the body. These include mechanical injuries, thermal extremes, infectious pathogens, chemical toxins, and , each capable of initiating through distinct mechanisms such as vascular or direct . Physical trauma represents a primary external cause of necrosis, where mechanical forces or thermal injuries lead to vascular disruption and subsequent tissue death. Mechanical injuries, such as crush wounds or lacerations, can sever blood vessels and cause immediate ischemia in affected areas, resulting in if not promptly addressed. Burns from extreme heat denature proteins and damage endothelial cells, often leading to vascular and localized necrosis, particularly in deep second- or third-degree burns. Similarly, from prolonged cold exposure induces and formation, disrupting cellular membranes and causing progressive necrosis in extremities like fingers and toes. Ischemia and , often resulting from external vascular compromise, deprive tissues of oxygen and nutrients, promoting necrotic . , where a clot or foreign material blocks an , can rapidly induce ischemia in downstream tissues, as seen in acute limb ischemia leading to gangrenous necrosis. External compression, such as from tight bandages or casts, similarly restricts blood flow, causing hypoxic necrosis in compressed regions like or muscles. Infections by external pathogens constitute another major category, with microbial toxins directly lysing cells or inducing widespread tissue destruction. Bacterial infections, exemplified by necrotizing fasciitis caused by Group A Streptococcus, release exotoxins that degrade fascia and subcutaneous tissues, leading to rapid liquefactive necrosis. Viral infections, such as herpes zoster, can cause necrotizing orbital or cutaneous lesions through direct cytopathic effects and vascular invasion. Fungal pathogens like Candida albicans or Mucorales species produce hyphae that invade vessels, resulting in thrombosis and ischemic necrosis, particularly in immunocompromised individuals. Toxins and chemicals from external sources can penetrate tissues and induce necrosis via cytotoxic effects. Snake venoms, containing metalloproteases and phospholipases, disrupt vascular integrity and cause local dermonecrosis, as observed in envenomations by species like Echis carinatus. Spider venoms, particularly from brown recluse (Loxosceles reclusa), contain sphingomyelinases that damage cell membranes and induce hemolytic necrosis at the bite site. Industrial solvents, such as xylene or tetrachloroethylene, can cause hepatic necrosis upon systemic absorption, with high doses leading to centrilobular cell death due to oxidative damage. Chronic alcohol exposure, acting as a hepatotoxic chemical, promotes centrilobular necrosis in the liver through hypoxia and reactive oxygen species generation. Radiation and environmental extremes further contribute to necrosis by altering cellular structures. Ionizing radiation from sources like X-rays or gamma rays damages DNA and vascular endothelium, leading to progressive skin and subcutaneous necrosis in high-dose exposures. Extreme temperatures beyond thermal trauma, such as hyperthermia from industrial heat, denature proteins and exacerbate ischemic necrosis in exposed tissues.

Internal factors

Internal factors contributing to necrosis arise from endogenous disruptions in physiological , including dysregulated enzymatic activity, aberrant immune responses, metabolic derangements, genetic anomalies, and neoplastic processes. These mechanisms often involve intrinsic cellular or vulnerabilities that compromise viability without external insults. Enzymatic digestion exemplifies an internal pathway to necrosis, particularly in , where premature activation of pancreatic proenzymes such as leads to autodigestion of pancreatic acinar cells. This process initiates a proteolytic cascade that degrades cellular structures, triggering and subsequent necrosis of pancreatic . In severe cases, up to 10-20% of episodes progress to necrotizing pancreatitis due to this enzymatic overactivation. Immune-mediated mechanisms induce necrosis through dysregulated inflammatory responses, as seen in autoimmune where antineutrophil cytoplasmic antibodies (ANCA) activate neutrophils to infiltrate and damage vessel walls, resulting in fibrinoid necrosis. Cytotoxic T cells and natural killer cells further contribute by releasing perforin and granzymes, forming pores in target cell membranes that lead to osmotic and necrotic during storms or hyperinflammatory states. These processes can escalate to widespread necrosis in conditions like . Metabolic imbalances promote necrosis by altering cellular environments, such as in hypercalcemia, where elevated serum calcium levels cause renal and direct to tubular epithelial cells, precipitating and potential progression to chronic kidney damage. Similarly, chronic hyperglycemia in diabetes mellitus impairs wound healing and microvascular perfusion in the lower extremities, heightening susceptibility to ischemic necrosis in ulcers through and neuropathy-induced trauma. Genetic predispositions underlie necrosis via inherited defects that impair enzymatic function or structural integrity, as in , where deficiency leads to accumulation, causing of bones through vascular occlusion and infarction. Mutations in genes, such as COL3A1 in vascular Ehlers-Danlos , confer vessel fragility, predisposing to spontaneous ruptures, ischemia, and downstream tissue necrosis in organs like the intestines or . Tumor-related necrosis occurs when rapid neoplastic proliferation outstrips vascular supply, inducing in central tumor regions and subsequent . This ischemic necrosis is prevalent in aggressive solid tumors, where proliferating cells beyond 100-200 μm from capillaries experience oxygen deprivation, leading to and potential release of damage-associated molecular patterns that fuel further tumor progression.

Pathogenesis

Molecular pathways

Necrosis encompasses several molecular pathways that drive uncontrolled , characterized by plasma membrane rupture and release of intracellular contents. One primary pathway is oncosis, which initiates with failure of ATP-dependent ion pumps, leading to Na⁺/K⁺ imbalance, osmotic cell swelling, and bleb formation on the plasma membrane. This energy depletion disrupts cellular , culminating in membrane permeabilization and , distinct from regulated forms of . A regulated variant, necroptosis, operates through a well-defined signaling cascade involving receptor-interacting 1 (), RIPK3, and mixed lineage kinase domain-like (MLKL). Upon stimulation by death ligands or pathogen sensors in the absence of activity, RIPK1 undergoes ubiquitination and phosphorylation, recruiting RIPK3 to form the necrosome complex via RHIM domain interactions. RIPK3 then phosphorylates MLKL, inducing its oligomerization and translocation to the plasma membrane, where it forms pores that disrupt ion balance and cause osmotic lysis. This pathway, first elucidated in seminal studies on TNF-induced , amplifies through damage-associated molecular patterns (DAMPs). Secondary necrosis arises when apoptotic cells evade timely , progressing to a . In this process, lysosomal membranes rupture, releasing hydrolytic enzymes that degrade cellular components and compromise integrity, leading to swelling and content leakage. This conversion, often observed under conditions of impaired clearance, shares morphological features with primary necrosis but stems from an initial apoptotic commitment. Across necrotic pathways, DAMPs such as high-mobility group box 1 (), ATP, and DNA fragments are released, acting as danger signals to propagate inflammation. binds Toll-like receptors (TLRs), particularly TLR4, while extracellular ATP activates P2X7 receptors on immune cells, triggering assembly and production like IL-1β. These signals recruit neutrophils and macrophages, exacerbating tissue damage in ischemic or infectious contexts. Recent advances highlight regulated necrosis's role in chronic inflammation, where necroptosis sustains autoimmune diseases via persistent DAMP signaling. In 2024-2025 studies, MLKL inhibitors have shown potential to "pause" necrosis, preserving cellular function in aging tissues and improving organ rejuvenation in mouse models of liver and neurodegeneration. Additionally, non-lytic MLKL signaling has been implicated in tissue regeneration, diverting necroptotic cells toward proliferative pathways in .

Histopathological changes

Necrosis manifests through a sequential series of microscopic alterations in affected cells and tissues, beginning with subcellular disruptions and culminating in inflammatory and reparative responses. These changes are driven by the failure of cellular , including imbalances that initiate dysfunction. Early histopathological features include mitochondrial swelling, which arises from impaired energy production and membrane permeability, and dilation of the due to calcium overload and protein synthesis arrest. Concurrently, plasma membrane blebbing forms as sublethal protrusions filled with cytoplasmic contents, preceding eventual rupture and spillage of intracellular material into the . Nuclear changes represent a defining progression in necrosis: pyknosis, characterized by chromatin condensation and nuclear shrinkage, occurs as DNA condenses irreversibly; this is followed by karyorrhexis, where the pyknotic nucleus fragments into irregular chromatin clumps; and karyolysis, the final enzymatic dissolution of nuclear material, rendering the nucleus indistinct. Cytoplasmic alterations involve a gradual loss of staining affinity, resulting in a pale, vacuolated appearance, alongside eosinophilic homogenization where denatured proteins impart a uniform, glassy texture to the cytoplasm. These effects reflect widespread proteolysis and organelle breakdown, distinguishing necrotic cells from viable ones under light microscopy. At the tissue level, necrotic foci elicit infiltration as an acute response to damage-associated molecular patterns released from dying cells, often accompanied by interstitial edema due to increased . In subsequent stages, unresolved necrosis may progress to macrophage-mediated clearance, with deposition for tissue repair, or formation if secondary occurs. The timeline of these changes varies by insult severity and tissue type; in acute scenarios such as myocardial infarcts, subcellular swelling emerges within 4-12 hours, nuclear pyknosis and early hypereosinophilia by 12-24 hours, influx by 1-3 days, and with by 10-14 days, leading to formation over weeks. necrosis, by contrast, unfolds over days to weeks, with persistent giving way to organized fibrotic replacement.

Clinical aspects

Signs and symptoms

Necrosis manifests through a variety of local and systemic clinical signs, depending on the affected tissue and extent of . Locally, affected areas often exhibit severe that may initially be intense and disproportionate to visible changes but can progress to numbness as tissues are compromised. Swelling and induration are common, accompanied by discoloration ranging from pale gray or blue to purple, black, bronze, or red hues, reflecting impaired blood flow and tissue breakdown. In cases of , such as , a foul odor may arise from necrotic tissue discharge, while gas-producing infections like produce —a crackling sensation under the skin due to subcutaneous gas bubbles. Systemic symptoms emerge particularly in extensive or infected necrosis, driven by inflammatory responses and potential bacterial spread. Patients may develop fever, , and general , progressing to with , confusion, and if the infection disseminates. In severe instances, such as from mesenteric ischemia, extensive necrosis can lead to , characterized by sudden abdominal distention, tenderness, and hemodynamic instability. Organ failure may ensue in widespread cases, contributing to multi-organ dysfunction (MODS) through unchecked and toxin release. Site-specific presentations highlight the diverse impacts of necrosis across body regions. In peripheral tissues, such as limbs affected by , initial severe pain often gives way to numbness and loss of sensation, with cool or cold skin to the touch. Myocardial necrosis, as seen in , typically presents with retrosternal chest pressure or pain radiating to the , , , or , alongside dyspnea, sweating, and . Cerebral necrosis from ischemic commonly causes unilateral neurological deficits, including facial droop, or leg weakness, slurred speech, vision impairment, and sudden severe headache with possible altered consciousness. Complications of necrosis can prolong morbidity and necessitate aggressive interventions. Unresolved necrotic tissue often results in chronic wounds that fail to heal due to persistent and bacterial biofilms, increasing risk and tissue loss. In limb-involving cases like , progression may lead to to prevent further spread. Extensive necrosis heightens the likelihood of MODS, where triggers cascading organ failures, significantly worsening prognosis.

Diagnosis

Diagnosis of necrosis typically begins with a thorough clinical evaluation, guided by symptoms such as persistent pain and swelling that suggest tissue damage. Physical examination involves careful inspection of the affected area for characteristic skin changes, including erythema, discoloration, blistering, or eschar formation, which indicate underlying tissue death. Palpation is essential to assess for tenderness disproportionate to visible inflammation, crepitus due to gas formation in infectious cases, or induration extending beyond the apparent lesion boundaries. Imaging modalities play a crucial role in confirming necrosis and delineating its extent. X-rays are often the initial imaging tool, particularly useful for detecting soft-tissue gas in cases like necrotizing fasciitis or gas gangrene, and for identifying bone collapse or sclerosis in avascular necrosis. Computed tomography (CT) provides detailed visualization of gas, fluid collections, and fascial involvement, offering superior assessment of disease spread compared to plain radiographs. Magnetic resonance imaging (MRI) is highly sensitive for early detection, revealing bone marrow edema, subchondral fractures, or non-viable tissue in avascular necrosis, while ultrasound excels at identifying subcutaneous gas, abscesses, or hypoechoic areas suggestive of fluid-filled necrotic regions. Laboratory tests support the diagnosis by indicating tissue damage and inflammation. Elevated levels of (LDH) serve as a of cellular necrosis due to its release from damaged cells, correlating with disease severity in conditions like sarcomas. (CRP) levels rise in response to inflammation accompanying necrosis, aiding in monitoring progression. For suspected infectious necrosis, blood cultures are critical to identify causative pathogens, such as in necrotizing soft-tissue infections. Biopsy remains the gold standard for definitive , providing histopathological confirmation. Hematoxylin and eosin (H&E) staining of tissue samples reveals hallmark nuclear changes, including , , and , distinguishing necrotic tissue from viable cells. can detect damage-associated molecular patterns (DAMPs), such as , which are abundantly released during necrosis and contribute to inflammatory signaling. In research settings, techniques such as using propidium iodide uptake have been refined (as of 2023) to differentiate necrosis from or necroptosis by assessing integrity at the single-cell level. Live-cell imaging allows observation of cellular changes like swelling and rupture in experimental models. Emerging AI-assisted analysis of MRI scans (as of 2025) supports grading, incorporating necrosis extent as a factor to improve prognostic assessment.

Treatment

Surgical interventions

Surgical interventions are critical in managing necrosis, particularly when the dead tissue poses risks of spread or systemic complications, aiming to excise necrotic areas and restore viable function. These procedures are guided by diagnostic imaging to delineate the extent of necrosis, ensuring targeted removal. Primary approaches include , , , and specific interventions like or , with early execution emphasized to improve . Debridement involves the systematic removal of necrotic to promote healing and prevent infection progression, applicable in conditions such as , , or . Sharp debridement, performed using instruments like scalpels, scissors, or curettes, selectively excises devitalized down to healthy margins, often requiring multiple sessions until viable is evident. Enzymatic debridement employs topical agents containing proteolytic enzymes to chemically lyse necrotic material, suitable for less extensive where sharp methods are contraindicated. Autolytic debridement leverages the body's endogenous enzymes and wound moisture, facilitated by occlusive dressings, to gradually soften and liquefy dead over days to weeks, ideal for selective, non-urgent cases. In , aggressive wide is the cornerstone, involving extensive excision of affected and surrounding to halt bacterial dissemination. Amputation is reserved for extensive limb necrosis, such as in advanced , where alone cannot salvage the extremity and life-threatening looms. This procedure involves transecting bone and proximal to the necrotic zone, with careful and beveling to minimize residual necrosis and facilitate prosthetic fitting. It is performed as a last resort to preserve overall survival, particularly in complications or . Revascularization addresses ischemic necrosis by restoring blood flow to hypoxic s, preventing further in conditions like critical limb ischemia. Endovascular uses balloon dilation to open occluded arteries, often combined with stenting for durability, while surgical grafting reroutes blood via synthetic or autologous grafts to bypass blockages. These interventions are prioritized when viable is potentially salvageable, with preferred for long-segment occlusions based on long-term patency . Specific procedures include for compartment syndrome-associated necrosis, where longitudinal incisions release fascial pressure to reperfuse ischemic muscle and avert further necrosis. In cases of abscess formation with necrotic content, evacuate purulent material and dead , often followed by to clear residual sources. Surgical interventions significantly reduce risk by eliminating necrotic that harbors pathogens and impedes , with early linked to lower rates of and improved survival. The 2025 Consensus on the Diagnosis and Treatment of Adult strongly recommends immediate incision, wide , and drainage as essential emergency measures, advocating repeated surgeries every 24-48 hours until necrosis is controlled, which has been associated with mortality reductions in high-risk cohorts. Overall outcomes emphasize timeliness, with within 6-24 hours of correlating to better preservation and reduced morbidity.

Medical and pharmacological approaches

In cases of infected necrosis, such as , broad-spectrum antibiotics are essential to target the underlying bacterial pathogens and halt progression. Regimens typically include a combination of β-lactam antibiotics like penicillin G or a with clindamycin, which inhibits toxin production by group A and other anaerobes, or as an alternative for its anti-toxin effects. For suspected involvement, , , or is added to the regimen. These therapies are administered intravenously and continued for 48-72 hours initially, with adjustments based on culture results, aiming to reduce systemic toxicity and support source control. Antioxidants and cytoprotectants play a key role in managing necrosis associated with ischemia-reperfusion injury by mitigating from . , a inhibitor, has demonstrated protective effects against myocardial and renal ischemia-reperfusion damage by reducing free radical production and preserving tissue viability. In experimental models, preconditioning attenuates histological damage and inflammation in affected organs, such as the heart and kidneys, by blocking the hypoxanthine- pathway. These agents are particularly useful in scenarios like post-transplant or complications where reperfusion exacerbates necrosis. For immune-mediated necrosis, such as in autoinflammatory or autoimmune conditions involving necroptosis, anti-inflammatory agents like corticosteroids or (TNF) inhibitors can modulate excessive cytokine-driven . Corticosteroids suppress inflammatory cascades that promote necrosis in diseases like or , while TNF inhibitors, including or , block TNF-α signaling to reduce damage and associated necrosis. Combination therapy with corticosteroids and TNF inhibitors has shown efficacy in managing immune-related endocrinopathies with necrotic components, improving outcomes by dampening necroptotic pathways. These treatments are selected based on the underlying to prevent progression without compromising immune surveillance. Emerging pharmacological approaches target regulated necrosis pathways like necroptosis for therapeutic intervention in inflammatory and degenerative diseases. MLKL inhibitors, such as novel small molecules or PROTACs, block mixed lineage kinase domain-like protein activation downstream of , attenuating necroptosis in conditions like and lung injury; for instance, calycosin-mediated MLKL inhibition reduces necrotic core formation and vascular in preclinical models. As of 2024-2025, these inhibitors are being explored for anti-aging applications by limiting age-related necrotic accumulation in tissues and for regeneration in ischemic injuries. Gene therapies targeting necroptosis, including CRISPR-based editing of or MLKL genes, show promise in preclinical studies for inflammatory diseases like and neurodegeneration, by selectively inhibiting necroptotic signaling to curb chronic without broad . Clinical translation remains in early phases, with ongoing trials focusing on safety and specificity. Supportive care complements these targeted therapies, with hyperbaric oxygen therapy (HBOT) enhancing in hypoxic necrotic tissues by increasing oxygen delivery to promote and combat . In necrotizing infections, adjunctive HBOT reduces mortality and the need for repeated debridements by limiting bacterial proliferation and necrotic extension, as evidenced in clinical series where it improved demarcation and tissue salvage. For , such as in osteonecrosis of the , HBOT facilitates integration and reduces when combined with other modalities. involves multimodal analgesia, including opioids and non-steroidal anti-inflammatory drugs, tailored to control discomfort from necrotic tissue breakdown while minimizing gastrointestinal or renal risks.

Necrosis in other organisms

In plants

In plants, necrosis refers to the localized death of cells or tissues, typically manifesting as or blackening, resulting from exposure to pathogens, toxins, or abiotic stresses such as or extreme temperatures. This process disrupts cellular integrity, leading to tissue collapse and potential spread if unchecked. Common causes include fungal and bacterial infections, which often trigger the —a mechanism that confines the by forming necrotic lesions at the infection site. Nutrient deficiencies, particularly calcium, can induce tip necrosis in young leaves, where impaired strengthening leads to breakdown and curling edges. Herbicides, especially auxinic types like 2,4-D, also provoke necrosis by mimicking hormones and causing uncontrolled growth followed by tissue death. Specific types encompass rapid necrosis observed in response to auxins, as seen in resistant Sumatran fleabane (Conyza sumatrensis), where environmental factors like high temperature accelerate symptom onset within hours of herbicide application, enhancing resistance mechanisms. Hybrid necrosis arises in interspecies crosses due to genetic incompatibilities, such as in Petunia species, where linked genes trigger autoimmune-like cell death and reproductive isolation. Detection methods rely on non-destructive techniques like imaging, which measures efficiency to quantify early necrotic damage, and electrolyte leakage assays that assess integrity through release from dying cells; recent advancements in 2025 have integrated these for precise heat stress evaluations. Notable examples include lethal necrosis disease (MLN), a co-infection causing severe foliar necrosis and up to 100% loss in affected fields across . In cacti, necrotic patches from bacterial infections provide habitats for diverse communities, supporting in desert ecosystems.

In animals

Necrosis manifests in various non-human animals, often as a response to , , ischemia, or environmental stressors, with significant implications for and . In , abdominal fat necrosis is a prevalent dystrophic-necrotic condition in , characterized by the formation of hard, irregular masses of necrotic in the due to overconditioning, , and dietary excess fat. This process can lead to severe reproductive disorders, including and dystocia, by compressing reproductive organs and impairing ovarian function, as observed in affected herds where productive strain exacerbates the issue. In , viral nervous necrosis (NNV), caused by betanodaviruses, induces widespread neuronal necrosis in over 50 species, leading to high mortality rates in larval and juvenile stages across global fisheries. Recent advancements include plant-based production of NNV antigens using genome-edited plants such as and . Plant-produced virus-like particles (VLPs) as vaccines have demonstrated protective efficacy against NNV in species like European sea bass by eliciting without adjuvants. Wildlife species exhibit unique adaptations involving for survival. For instance, blind mole rats ( spp.) employ a regulated necrotic mechanism, activated via the RIP1/RIP3 pathway, to eliminate precancerous cells and confer exceptional cancer resistance, even under hypoxic burrow conditions. Pathological examples highlight 's role in acute veterinary emergencies. In horses, intestinal from strangulating lesions, such as or epiploic entrapment, is a leading cause of , resulting in ischemia-reperfusion injury and rapid tissue death if untreated. In swine, disease can trigger granulomatous necrotizing , featuring muscle fiber and that impair mobility and growth. Contemporary research leverages animal models to translate regulated necrosis insights to diseases, particularly through studies on damage-associated molecular patterns (DAMPs). For example, investigations in models have shown that necroptosis and other regulated necrotic pathways release DAMPs like , perpetuating chronic in conditions mirroring human sepsis and neurodegeneration. These findings underscore necrosis's dual role as a pathological driver and therapeutic target in translational veterinary science.

References

  1. [1]
    Necrosis Pathology - StatPearls - NCBI Bookshelf - NIH
    It is an uncontrolled cell death that results in swelling of the cell organelles, plasma membrane rupture and eventual lysis of the cell.
  2. [2]
    Diversity and complexity of cell death: a historical review - Nature
    Aug 23, 2023 · Necrosis is an uncontrolled and pathological form of cell death, marked by cell swelling, membrane rupture, and intracellular content release, ...
  3. [3]
    Definition of bone necrosis by the pathologist - PMC - NIH
    Necrosis is the cell death due to an irreversible external injury, which is recognizable microscopically by alterations in the nucleus (swelling, pyknosis, ...
  4. [4]
    What Is Necrosis? Types & Causes - Cleveland Clinic
    Aug 9, 2022 · With coagulative necrosis, the dead cells remain firm and look normal for days after death. Lack of blood flow or oxygen to any part of your ...
  5. [5]
    Inflammatory outcomes of apoptosis, necrosis and necroptosis
    Certain molecules, which have been dubbed 'damage-associated molecular patterns' (DAMPs) or alarmins, are thought to promote inflammation upon release from ...
  6. [6]
    Necrosis: MedlinePlus Medical Encyclopedia
    Sep 18, 2023 · Necrosis is the death of body tissue. It occurs when too little blood flows to the tissue. This can be from injury, radiation, or chemicals.
  7. [7]
    Cell Death, Damage-Associated Molecular Patterns, and Sterile ...
    This review examines cell death in vascular disease, how it can induce inflammation, and finally the emergence of inflammasomes in vascular pathology.
  8. [8]
    Mechanisms of Cell Death: Necrosis & Necroptosis - CST Blog
    Rupture of the cell, which is characteristic of necrosis, leads to leakage of the cellular contents into the extracellular space.
  9. [9]
    Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of ...
    Necrosis is a term used by pathologists to designate the presence of dead tissues or cells and is the sum of changes that have occurred in cells after they ...
  10. [10]
    Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
    Mar 30, 2021 · Here, we summarize the latest discoveries in the three most well understood modalities of cell death, namely, apoptosis, necroptosis, and pyroptosis.
  11. [11]
    Roles of RIPK3 in necroptosis, cell signaling, and disease - Nature
    Oct 12, 2022 · Receptor-interacting protein kinase-3 (RIPK3, or RIP3) is an essential protein in the “programmed” and “regulated” cell death pathway called necroptosis.
  12. [12]
    Expansion and Evolution of Cell Death Programmes - PubMed - NIH
    Cell death includes apoptosis, a regulated death, and necrosis, an unregulated death. Recent data suggests multiple non-apoptotic, regulated cell death ...
  13. [13]
    The evolution of cell death programs as prerequisites of multicellularity
    Necrotic (accidental) cell death results from a variety of stresses, such as extreme physicochemical injury (radicals, radiation, temperature, toxic trauma, ...
  14. [14]
    Gangrene - StatPearls - NCBI Bookshelf - NIH
    Jul 20, 2025 · The condition is commonly classified into dry, wet, and gas gangrene. Dry gangrene typically results from progressive ischemia and is most ...Continuing Education Activity · Introduction · Etiology · History and Physical
  15. [15]
    Gangrene - Symptoms & causes - Mayo Clinic
    Jun 17, 2022 · Types of gangrene · Dry gangrene. This type of gangrene involves dry and shriveled skin that looks brown to purplish blue or black. · Wet gangrene ...
  16. [16]
    Gangrene: Symptoms, Causes & Treatment - Cleveland Clinic
    Types of gangrene ; Dry gangrene. This is when blood ; Wet gangrene. This is disrupted blood flow along with a bacterial infection ; Gas gangrene ; Fournier's ...
  17. [17]
    Osteonecrosis in sickle cell disease: an update on risk factors ... - NIH
    Dec 6, 2019 · Osteonecrosis, a form of ischemic bone injury that leads to degenerative joint disease, affects ∼30% of people with sickle cell disease.
  18. [18]
    Radiation Necrosis: Background, Pathophysiology, Epidemiology
    Jul 20, 2021 · Radiation necrosis can occur when radiotherapy is used to treat primary CNS tumors, metastatic disease, or head and neck malignancies. It can ...
  19. [19]
    The necrotic venom of the brown recluse spider induces ... - NIH
    Brown recluse spider (Loxosceles reclusa) venom induces severe dermonecrotic lesions. The mechanism for this is unknown but presents an interesting paradox: ...Missing: chemical | Show results with:chemical
  20. [20]
    Role of hypoxia in cancer therapy by regulating the tumor ...
    Nov 11, 2019 · Such chronic hypoxia or diffusion-restricted hypoxia causes the necrosis of tumor cells within the 180-μm periphery of blood vessels.
  21. [21]
    Cancer resistance in the blind mole rat is mediated by concerted ...
    Abrogation of ECI makes naked mole rat cells more prone to malignant transformation. Naked mole rats inhabit East Africa and belong to the Hystricognath group ...
  22. [22]
    Necrosis: Symptoms, Causes, and Treatments
    Necrosis is irreversible cell death due to injury or trauma. You must remove all dying tissue to prevent further injury to the area.What Is Necrosis? · When Should You Contact A... · What Causes Necrosis?Missing: importance | Show results with:importance<|separator|>
  23. [23]
    Necrosis: Symptoms, Causes, Risk Factors, Treatment
    Jan 16, 2024 · Necrosis is the death of tissues of the body. It can be caused by many factors like insufficient oxygen, infection, trauma, or radiation therapy.
  24. [24]
    Complications Post Burns - Physiopedia
    The injuries can be caused by friction, cold, heat, radiation, chemical or electric sources, but the majority of burn injuries are caused by heat from hot ...
  25. [25]
    Frostbite - StatPearls - NCBI Bookshelf - NIH
    Frostbite, also known as freezing cold injury is tissue damage that occurs due to cold exposure, occurring at temperatures below zero degrees celsius.
  26. [26]
    Acute Pulmonary Embolism - StatPearls - NCBI Bookshelf - NIH
    Acute pulmonary embolism (PE) occurs when a blood clot that has arisen from another area obstructs the pulmonary arteries. PE typically originates as a deep ...<|separator|>
  27. [27]
    Acute Limb Ischemia—Much More Than Just a Lack of Oxygen - NIH
    Acute ischemia of an extremity occurs in several stages, a lack of oxygen being the primary contributor of the event. Although underlying patho-mechanisms ...
  28. [28]
    Necrotizing Fasciitis - StatPearls - NCBI Bookshelf
    Necrotizing fasciitis is a subset of aggressive skin and soft tissue infections that cause muscle fascia and subcutaneous tissue necrosis.
  29. [29]
    Necrotizing orbital infections: A comprehensive review - PMC
    Infections caused by bacterial, fungal, or viral pathogens can lead to tissue ischemia, necrosis, and serious consequences, including vision loss, intracranial ...Necrotizing Fungal Orbital... · Mucormycosis · Necrotizing Viral Infections<|separator|>
  30. [30]
    Candida albicans necrotizing fasciitis following elective surgery - PMC
    Necrotizing fasciitis is a potentially fatal soft tissue infection that requires prompt clinical suspicion, pharmacological and surgical interventions.
  31. [31]
    Echis carinatus snake venom metalloprotease-induced toxicities in ...
    Feb 2, 2021 · The abundant presence of zinc (Zn++) metalloproteases in Echis carinatus venom (ECV) is responsible for local tissue necrosis. An earlier report ...
  32. [32]
    Brown Recluse Spider Toxicity - StatPearls - NCBI Bookshelf
    Aug 7, 2023 · One of the active enzymes in the venom causes significant damage to blood vessels and cell death to the tissue at the envenomation site.
  33. [33]
    Toxic hepatitis in occupational exposure to solvents - PMC
    Jun 14, 2012 · After steatosis, necrosis is the second most common effect of liver damage as a result of hepatotoxic solvents. It is the result of destruction ...
  34. [34]
    Experimental alcohol-induced hepatic necrosis - PubMed
    We propose that this alteration produces a relative hypoxia in the centrilobular zone of the liver which, if severe enough, leads to cellular death and to the ...
  35. [35]
    SUMMARY OF HEALTH EFFECTS OF IONIZING RADIATION - NCBI
    The highest dose of 25,600 rad (256 Gy) caused skin necrosis at the end of the second week and well-delimited ulceration by the third week. After doses of ...
  36. [36]
    Combined Hyperthermia and Radiotherapy for the Treatment of ...
    Hyperthermia is a potent sensitizer of cell killing by ionizing radiation (IR), which can be attributed to the fact that heat is a pleiotropic damaging agent.
  37. [37]
    Acute Pancreatitis - StatPearls - NCBI Bookshelf - NIH
    Aug 2, 2025 · Premature activation of digestive enzymes within the pancreas initiates a cascade of acinar cell injury, systemic inflammation, and pancreatic ...
  38. [38]
    [Pathogenesis of acute pancreatitis] - PubMed
    Sep 16, 2021 · Acute pancreatitis is characterized by the autodigestion of the pancreas by its own digestive enzymes.
  39. [39]
    Mechanisms of vascular damage in ANCA vasculitis - PubMed Central
    Mar 7, 2022 · Inflammatory cell infiltration of the small blood vessel walls leading to vascular injury and tissue necrosis is the hallmark of ANCA vasculitis ...
  40. [40]
    Vasculitis: mechanisms involved and clinical manifestations - PMC
    Systemic vasculitis, an inflammatory necrotizing disease of the blood vessel walls, can occur secondary to autoimmune diseases, including connective tissue ...
  41. [41]
    Cytokine Storm—Definition, Causes, and Implications - PMC
    The proinflammatory components cause inflammation which, if systemic, can lead to progressive tissue damage and to organ dysfunction.
  42. [42]
    Acute renal failure and hypercalcemia - PubMed
    Hypercalcemia may also provoke acute renal failure (ARF) or hypertension, or aggravate the tubular necrosis that is frequently found in cases of ARF.
  43. [43]
    Hyperglycemia Increases Susceptibility to Ischemic Necrosis - PMC
    Nov 15, 2012 · Tissue necrosis plays a primordial role in the progression of diabetic foot ulcers but the underlying mechanisms are poorly understood.
  44. [44]
    Genetics of enzymatic dysfunctions in metabolic disorders and cancer
    Sphingolipidoses can lead to several diseases, the most common are Gaucher's disease (GD), Fabry disease, Farber disease, and Niemann-Pick disease. The most ...
  45. [45]
    vascular ehlers-danlos syndrome: Topics by Science.gov
    Ehlers-Danlos syndrome refers to a spectrum of connective tissue disorders typically caused by mutations in genes responsible for the synthesis of collagen.
  46. [46]
    Tumor hypoxia unveiled: insights into microenvironment, detection ...
    Oct 3, 2024 · These regions arise due to rapid tumor growth outpacing the supply of functional blood vessels, leading to oxygen deprivation. Low oxygen ...
  47. [47]
    Apoptosis, oncosis, and necrosis. An overview of cell death - PMC
    Oncosis leads to necrosis with karyolysis and stands in contrast to apoptosis, which leads to necrosis with karyorhexis and cell shrinkage.
  48. [48]
    Oncosis - an overview | ScienceDirect Topics
    The mechanisms leading to oncosis have not been investigated in detail but some evidence suggests that failure of ionic pumps and ATP depletion may be among the ...
  49. [49]
    Necroptosis: a crucial pathogenic mediator of human disease
    Aug 8, 2019 · Necroptotic cell death mediated by RIPK1/RIPK3 and/or MLKL may play a role in human diseases. In the context of infectious disease, necroptotic ...
  50. [50]
    MLKL post-translational modifications: road signs to infection ...
    Sep 29, 2022 · Necroptosis is a caspase-independent modality of cell death that requires the activation of the executioner MLKL. In the last ten years the ...Mlkl Structure And... · Mlkl In Viral Infection · Mlkl Ubiquitination
  51. [51]
    Necroptosis: a regulated inflammatory mode of cell death
    Jul 6, 2018 · Necroptosis is an alternative mode of regulated cell death mimicking features of apoptosis and necrosis.
  52. [52]
    Secondary necrosis: The natural outcome of the complete apoptotic ...
    Nov 19, 2010 · Secondary necrosis is a mode of cell elimination with specific molecular and morphological features and should be considered the natural outcome of the ...
  53. [53]
    Secondary necrosis in multicellular animals: an outcome of ...
    Secondary necrosis involves activation of self-hydrolytic enzymes, and swelling of the cell or of the apoptotic bodies, generalized and irreparable damage to ...
  54. [54]
    Release mechanisms of major DAMPs - PMC - PubMed Central
    DAMPs can be released passively by membrane rupture due to necrosis/necroptosis, although the mechanisms of release appear to differ between the DAMPs.
  55. [55]
    DAMPs from Cell Death to New Life - Frontiers
    DAMPs have been linked to inflammation and related disorders: hence, inhibition of DAMP-mediated inflammatory responses is a promising strategy to improve ...
  56. [56]
    RIPK1 in necroptosis and recent progress in related pharmaceutics
    Feb 10, 2025 · RIPK1, RIPK3, and mixed-lineage kinase-like domain (MLKL) proteins mediate necrosis. RIPK1-mediated necroptosis further promotes cell death and ...
  57. [57]
    Impact of Mlkl or Ripk3 deletion on age-associated liver ...
    Feb 10, 2025 · The findings reveal that inhibiting necroptosis through Mlkl and Ripk3 knockouts drives adaptive changes in liver function, particularly ...
  58. [58]
    Necroptosis Regulation: Balancing Life and Death
    Apr 17, 2025 · A new study reveals the dual role of MLKL in necroptosis, paving the way for new treatments for inflammatory diseases.
  59. [59]
    Recommendations from the INHAND Apoptosis/Necrosis Working ...
    This article provides guidance on the identification and diagnosis of apoptosis ... The distinction between apoptosis and single cell necrosis is easier in some ...
  60. [60]
    Educational Case: Myocardial Infarction: Histopathology and Timing ...
    Dec 17, 2020 · What Is an MI? Myocardial infarction, commonly called a heart attack, is the death of cardiac muscles as a result of prolonged severe ischemia.
  61. [61]
    Gas Gangrene - StatPearls - NCBI Bookshelf
    It is synonymous with myonecrosis and is characterized by rapidly progressive gangrene of the injured tissue and the production of foul-smelling gas.
  62. [62]
    Intestinal ischemia - Symptoms and causes - Mayo Clinic
    Sep 11, 2024 · Sudden belly pain. · An urgent need to pass stool. · Forcefully passing stool often. · Belly tenderness or bloating, also called distention.
  63. [63]
    Myocardial Infarction - StatPearls - NCBI Bookshelf - NIH
    Aug 8, 2023 · Prolonged deprivation of oxygen supply to the myocardium can lead to myocardial cell death and necrosis. Patients can present with chest ...
  64. [64]
    Stroke - Symptoms and causes
    ### Summary of Stroke Symptoms Leading to Cerebral Necrosis (Including Neurological Deficits)
  65. [65]
    Factors Affecting Wound Healing - PMC - NIH
    The factors discussed include oxygenation, infection, age and sex hormones, stress, diabetes, obesity, medications, alcoholism, smoking, and nutrition.The Wound-Healing Process · Obesity · Nutrition
  66. [66]
    Necrotizing Fasciitis: How Reliable are the Cutaneous Signs? - PMC
    Necrosis of the tissues and fascia may manifest as erythema without sharp margins, swelling, warmth, shiny, and exquisitely tender areas. Pain out of proportion ...
  67. [67]
    Avascular necrosis (osteonecrosis) - Diagnosis & treatment
    During a physical exam, a healthcare professional will press around joints, checking for tenderness. ... Imaging tests can help pinpoint the source of pain.Missing: biopsy | Show results with:biopsy
  68. [68]
    Necrotizing Fasciitis and Its Mimics: What Radiologists Need to Know
    CT is the most sensitive modality for soft-tissue gas detection, and compared with radiography, CT is superior to evaluate the extent of tissue or osseous ...
  69. [69]
    Osteonecrosis Imaging - StatPearls - NCBI Bookshelf
    May 25, 2024 · Imaging modalities used to evaluate osteonecrosis include plain radiographs, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine ...
  70. [70]
    Avascular Necrosis (AVN) of the Femoral Head Imaging and ...
    Dec 27, 2021 · MRI is the most sensitive means of diagnosing avascular necrosis. This imaging modality provides the criterion standard of noninvasive ...Missing: physical | Show results with:physical
  71. [71]
    The Prognostic Role of the C-Reactive Protein and Serum Lactate ...
    Jun 22, 2022 · In our study, LDH levels at diagnosis were strongly correlated with the prognosis, and they might be considered a prognostic factor in Ewing sarcoma.
  72. [72]
    Isolated tuberculous liver abscess in an immunocompetent adult ...
    Laboratory data showed leukocytosis, an elevated C-reactive protein (CRP) level, a mildly elevated erythrocyte sedimentation rate (ESR), and hyponatremia.
  73. [73]
    Early diagnosis of necrotizing fasciitis: Imaging techniques and their ...
    Various tests have been used to diagnose NF, with laboratory assays being the most used diagnostic method. Abnormalities in various inflammatory indicators can ...Missing: biopsy | Show results with:biopsy
  74. [74]
    Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) of ...
    Jan 5, 2015 · H&E staining of left axillary lymph node biopsy (400× magnification), demonstrating necrotic areas with absence of neutrophilic infiltration.
  75. [75]
    Damage-Associated Molecular Patterns in Inflammatory Diseases
    Aug 13, 2018 · DAMPs are endogenous danger molecules that are released from damaged or dying cells and activate the innate immune system by interacting with pattern ...
  76. [76]
    Discriminating Between Apoptosis, Necrosis, Necroptosis, and ...
    Dec 19, 2023 · This unit describes protocols for the measurement of apoptosis and necrosis and for distinguishing apoptosis from programmed as well as conventional necrosis.
  77. [77]
  78. [78]
    Toward New Assessment in Sarcoma Identification and Grading ...
    Jul 2, 2025 · While genetic data identifies key molecular drivers, AI can analyze imaging data to predict malignancy grades and detect subtle patterns ...
  79. [79]
    Surgical management of severe lower extremity injury - UpToDate
    At initial operation, devitalized tissue and foreign material are surgically debrided from the wound. The location ...
  80. [80]
    Necrotic Wound Management | WoundSource
    Feb 13, 2020 · Sharp debridement is performed by a skilled clinician using a curette, scalpel, scissors, or forceps to remove devitalized tissue to a viable ...
  81. [81]
    Incision, Drainage, and Debridement Technique
    Aug 25, 2020 · Chemical debridement is performed by using certain enzymatic chemicals on the wound that cause lysis of the necrotic tissue in the wound.
  82. [82]
    Debridement | UCSF Department of Surgery
    Autolytic Debridement - This uses the body's own enzymes and moisture to re-hydrate, soften, and liquefy non-viable tissue. Autolytic debridement is selective ...
  83. [83]
    [PDF] Approach to debridement in necrotizing fasciitis - Dr. Wong Chin Ho
    Abstract. Aggressive debridement is a cornerstone intervention in necrotizing fasciitis. Our approach consists of 4 steps: (1) confirming the diagnosis and ...<|separator|>
  84. [84]
    [PDF] Surgical Considerations in Lower Extremity Amputation
    –Minimize wound necrosis. • Hemostasis prior to closure. –Drains. Page 21. Bone. • Minimize sharp edges. – Beveling/filing. • Narrow metaphyseal flare/condyles.
  85. [85]
    Surgical strategies for prevention of amputation of the diabetic foot
    The debridement often necessitates the need for large surgical incisions to reach and excise the necrotic tissue completely to the healthy normal tissue.
  86. [86]
    Which is the best revascularization for critical limb ischemia
    The long-term results of the Bypass Versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial favor surgery rather than angioplasty if there is a good vein ...
  87. [87]
    Strategy of Revascularization for Critical Limb Ischemia Due to ...
    Physicians performing revascularization should always consider bypass surgery to the foot as the second procedure for cases in which revascularization cannot be ...
  88. [88]
    Fasciotomy Wound Management - Compartment Syndrome - NCBI
    Sep 3, 2019 · Surgical fasciotomy is the only effective treatment, offering an immediate decrease in the compartment pressure and an increase in the volume ...
  89. [89]
    Time is of the essence when treating necrotizing soft tissue infections
    Jan 8, 2020 · Early surgical treatment does not only reduce the mortality rate, but several studies also found that it can reduce the risk of septic shock, ...
  90. [90]
    Consensus on the Diagnosis and Treatment of Adult Necrotizing ...
    Recommendation 6 (highly recommended): Incision, debridement, and drainage are essential components of emergency treatment for NF. Surgery should be performed ...Abstract · Background · Methods · Clinical questions and...
  91. [91]
    Necrotizing Soft Tissue Infections: A Review | Surgery - JAMA Network
    Sep 11, 2024 · Early surgical debridement is crucial for improved outcomes and should be performed as soon as possible, ideally within 6 hours of presentation.
  92. [92]
    Necrotizing Fasciitis Medication: Antibiotics - Medscape Reference
    Sep 4, 2024 · Possible regimens include a combination of penicillin G and an aminoglycoside (if renal function permits), as well as clindamycin (to cover streptococci, ...
  93. [93]
    Antibiotics in Necrotizing Soft Tissue Infections - PMC - NIH
    Sep 13, 2021 · Vancomycin, linezolid, or daptomycin should be added to a beta-lactam regimen in case of identified risk factors for MRSA infections.
  94. [94]
    Antibiotic therapy in necrotizing soft tissue infections - Critical Care
    Oct 10, 2025 · We recommend a combination of β-lactam and anti-toxin antibiotics for the first 48–72 h of treatment. Linezolid is non-inferior to clindamycin ...
  95. [95]
    Allopurinol Protects against Ischemia/Reperfusion-Induced Injury in ...
    Allopurinol is an inhibitor of xanthine oxidase (XO) and thus can serve as an antioxidant that reduces oxidative stress.
  96. [96]
    Remote post-conditioning and allopurinol reduce ischemia ... - NIH
    The aim of this study was to evaluate the effects of the antioxidant allopurinol and ischemic post-conditioning on the deleterious effects of ischemia ...
  97. [97]
    Xanthine Oxidase Inhibitor, Allopurinol, Prevented Oxidative Stress ...
    Jun 7, 2015 · In conclusion, the results of our study suggest that allopurinol treatment is capable of protecting heart of ISO induced myocardial infarction ...
  98. [98]
    Tumor necrosis factor inhibitors enhance corticosteroid therapy for ...
    Aug 6, 2024 · This study evaluates the effectiveness and safety of combination therapy with corticosteroids and tumor necrosis factor inhibitors (TNFi) in treating irEN ...
  99. [99]
    Inhibition of tumor necrosis factor improves conventional steroid ...
    Tumor necrosis factor (TNF) α inhibitors are biologic medications that suppress TNF-α pathways. They have been approved to treat a variety of inflammatory ...
  100. [100]
    The role of necroptosis in disease and treatment - PMC
    Inhibition of necroptosis could reduce cell death, meanwhile making the inflammatory response to be a protective reaction. Yang et al. showed that ischemia ...
  101. [101]
    Advances in MLKL-targeted inhibitors and PROTACs for necroptosis ...
    This review highlights recent advances in the development of necroptosis inhibitors and degraders targeting MLKL.Missing: blockers | Show results with:blockers
  102. [102]
    MLKL as an emerging machinery for modulating organelle dynamics
    Pharmacological inhibition of MLKL with calycosin significantly improves atherosclerosis, reducing necrotic core area and vascular inflammation, as well as foam ...Missing: blockers | Show results with:blockers
  103. [103]
    Targeted inhibition of MLKL-mediated necroptosis attenuates ...
    Oct 15, 2025 · Mlkl-/- or inhibitors alleviate arsenic-induced lung injury by blocking necroptosis. Abstract. Arsenic, a ubiquitous environmental toxicant, ...
  104. [104]
    Targeting necroptosis: a promising avenue for respiratory disease ...
    Aug 28, 2024 · Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
  105. [105]
    Hyperbaric oxygen in the management of wound tissue necrosis ...
    This report describes the use of HBO as an excellent adjuvant treatment for a case of tissue necrosis post-ExtDCR that was unresponsive to conventional therapy.
  106. [106]
    The effect of hyperbaric oxygen therapy on the clinical outcomes of ...
    Mar 25, 2023 · HBO can alleviate inflammation, reduce inflammatory immune cytokines, stimulate wound repair, maintain wound oxygenation, increase antioxidant ...
  107. [107]
    Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality ...
    This study evaluates how the addition of hyperbaric oxygen (HBO) therapy to surgical treatment has affected mortality and the number of debridements required ...
  108. [108]
    How Hyperbaric Oxygen Helps Treat Avascular Necrosis
    Nov 15, 2023 · HBO therapy is particularly useful for people with avascular necrosis in combination with stem cell treatments. “Stem cells are very beneficial ...
  109. [109]
    Detection and measurement of necrosis in plants - PubMed
    When plants or plant cell cultures are subjected to abiotic stress they initiate rapid cell death with necrotic morphology. Likewise, when plants are attacked ...
  110. [110]
    Morphological classification of plant cell deaths - Nature
    Apr 15, 2011 · Necrosis is characterised by early rupture of the plasma membrane, shrinkage of the protoplast and absence of vacuolar cell death features.<|separator|>
  111. [111]
    The hypersensitive response facilitates plant infection by the ...
    This is called the hypersensitive response (HR) and is considered to be a major element of plant disease resistance. The HR is thought to deprive the pathogens ...
  112. [112]
    THE SYMPTOMS OF CALCIUM DEFICIENCY IN PLANTS - 1978
    Eventually the tissue may become desiccated yielding a dry, more or less extensive area of necrosis. Two mechanisms are proposed. There is evidence that calcium ...
  113. [113]
    [PDF] Illustrated Definitions of Plant Problems - Purdue Extension
    Necrosis – death of tissue through injury ... Vascular Discoloration – change in color of the water- transport tissues of the plant caused by infection in.
  114. [114]
    Rapid necrosis: Implications of environmental conditions and plant ...
    Mar 24, 2023 · This study aimed to investigate the effect of environmental conditions, plant growth stage, and simultaneous and sequential herbicide mixtures with other auxin ...Missing: auxins | Show results with:auxins
  115. [115]
    A novel method for measuring heat injury in leaves provides insights ...
    Jul 1, 2025 · The degree of heat damage can be measured by various methods: electrolyte leakage, chlorophyll fluorescence (maximum PSII efficiency, Fv/Fm) ...
  116. [116]
    Maize Lethal Necrosis disease: review of molecular and genetic ...
    Nov 23, 2022 · In 2011, MLN was first reported in south-western Kenya [1]. MLN-affected plots recorded yield loss worth US$ 53.2 million in 2012, $180 million ...
  117. [117]
    [PDF] Arthropod diversity in necrotic tissue of three
    Abstract-We compared the insect and arachnid species found in spring and sum- mer samples of necrotic tissue of three species of columnar cacti, card6n.Missing: habitats | Show results with:habitats
  118. [118]
    Abdominal Fat Necrosis in Animals - Digestive System
    Overconditioning, genetic factors, and lack of exercise may be associated with fat necrosis in cattle. Hard masses of necrotic fat form in the omentum, ...
  119. [119]
    Severe Reproductive Disorders After Abdominal Fat Necrosis in ...
    Abdominal fat necrosis is a dystrophic–necrotic process that is relatively common in dairy cows. It is determined by productive strain (excess fat in the ...
  120. [120]
    Plant-Made Nervous Necrosis Virus-Like Particles Protect Fish ...
    The data indicate that the plant-made VLPs, even in the absence of immune promoting adjuvant, can significantly protect sea bass against NNV. TABLE 1. www.
  121. [121]
    Production and characterization of nervous necrosis virus vaccine ...
    Mar 15, 2025 · Plant-made nervous necrosis virus-like particles protect fish against disease. Front. Plant Sci., 10 (2019), p. 880, 10.3389/fpls.2019.00880.
  122. [122]
    Cancer resistance in the blind mole rat is mediated by ... - PNAS
    Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism. Vera Gorbunova vera.gorbunova@rochester.edu, Christopher Hine ...
  123. [123]
    A cellular necrosis process model for estimating conifer crown scorch
    We used the “lag” model to describe time- and temperature-dependent leaf cell necrosis as a method of predicting leaf scorch.
  124. [124]
    Diseases Associated with Colic in Horses by Anatomic Location
    The most common cause of gastric dilatation in horses is excessive gas or intestinal obstruction. Gastric dilatation may be associated with overeating ...
  125. [125]
    Granulomatous Necrotizing Myositis in Swine Affected by Porcine ...
    ... necrotizing myositis should be considered as another expression of PCV2 infection in pigs. Keywords: myopathy; pigs; porcine circovirus; swine diseases.Missing: dermatomyositis | Show results with:dermatomyositis
  126. [126]
    Life-threatening risk factors contribute to the development of ... - Nature
    Apr 11, 2025 · The release of DAMPs typically occurs when cells undergo necrosis, and consequent membrane rupture leads to the leakage of intracellular ...
  127. [127]
    Damage-associated molecular patterns (DAMPs) in diseases
    Aug 29, 2025 · Research has demonstrated that DAMPs play pivotal roles in various diseases, including cancer, cardiovascular disorders, and pulmonary diseases, ...